Target intelligence / Profile preview

Candida albicans DNA (C. albicans DNA)

Target
C. albicans DNA
Molecular classification
Nucleic acid, Genome
01

Overview

Candida albicans DNA is the complete set of genetic instructions for this opportunistic fungal pathogen, organized into eight pairs of homologous chromosomes (Source: Nature Reviews Microbiology). It serves as the primary template for replication and transcription, enabling the fungus to adapt to host environments and undergo morphological transitions critical for virulence (Source: Genetics). While most antifungal agents target the cell membrane, Candida albicans DNA is the indirect target of the antimetabolite drug flucytosine, which is converted into 5-fluorouracil to inhibit DNA synthesis (Source: StatPearls). Additionally, certain DNA-binding compounds like pentamidine can interact directly with the fungal DNA structure to disrupt cellular function (Source: PubMed). In clinical settings, the detection of specific sequences within Candida albicans DNA via PCR is a gold standard for the rapid diagnosis of invasive candidiasis (Source: Journal of Clinical Microbiology). The genome's high plasticity, including frequent chromosomal rearrangements, facilitates the rapid development of antifungal resistance (Source: Nature Reviews Microbiology).

Other names
Candida albicans genomeC. albicans genomic DNACandida albicans nucleic acid
02

Mechanism of action

Inhibition of DNA synthesis through metabolic interference or direct binding to the DNA structure to disrupt replication and transcription (Source: StatPearls, PubMed).

03

Biological functions

Genetic information storageDNA replicationTranscriptionMorphological transition regulation
04

Disease associations

Invasive candidiasisCandidemiaOral thrushVulvovaginal candidiasisInfection
05

Safety considerations

Bone marrow suppressionHepatotoxicityAntifungal resistance developmentPotential for host DNA cross-reactivity
06

Interacting drugs

Flucytosine

2 more in the full profile.

07

Biomarkers

Candida albicans DNA (PCR detection)

Beyond the preview

Go deeper on Candida albicans DNA (C. albicans DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida albicans DNA (C. albicans DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call